HI Form 4: Executive RSU vesting and partial share sale reported

Rhea-AI Filing Summary

Insider transactions by Tamara Morytko, Sr. VP & President, MTS at Hillenbrand, Inc. (HI) show restricted stock units vesting and a partial sale of common stock on 09/11/2025. 4,245 Restricted Stock Units (granted 09/11/2023) were recorded as acquired/vested with a $0 per-share conversion value and dividend-equivalent rights. On the same date, 1,997 shares of common stock were disposed of at $25.365 per share. Post-transaction beneficial ownership figures in the filing are presented as 7,668 and 5,671 shares in the non-derivative table and 8,498 shares in the derivative table reflecting RSU holdings. The form is signed by an Attorney-in-Fact on 09/15/2025.

Insights

Corporate Governance Expert

TL;DR: Insider recorded RSU vesting and a contemporaneous partial sale; transactions appear routine and aligned with compensation vesting.

The filing documents the vesting of 4,245 Restricted Stock Units and a sale of 1,997 shares at $25.365. The RSUs carry dividend-equivalent rights and a multi-year vesting schedule. There is no indication in this filing of unusual timing or policy deviations; the transactions are consistent with standard executive compensation mechanics. Beneficial ownership totals are disclosed separately for non-derivative and derivative positions.

Securities Analyst

TL;DR: The transactions are modest in size and detail typical conversion/vesting activity plus a partial disposition, suggesting limited market impact.

The form shows RSU conversion (4,245 units) and a market sale of 1,997 shares at $25.365. Reported post-transaction ownership figures are included for transparency. No additional material events, changes to compensation policy, or company-level financial data are disclosed, limiting investor implications to standard insider liquidity and comp vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morytko Tamara

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr. VP & President, MTS

3. Date of Earliest Transaction (Month/Day/Year)
09/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/11/2025		M		4,245	A	$0(1)	7,668	D
Common Stock	09/11/2025		F		1,997	D	$25.365	5,671	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 09/11/2023)	(1)	09/11/2025		M(2)			4,245	(3)	(3)	Common Stock	4,245	$0	8,498	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-quarter on 9/11/2024, one-quarter on 9/11/2025, and one-half on 9/11/2026.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-Fact for Tamara Morytko	09/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Tamara Morytko report on Form 4 for HI?

The Form 4 reports the vesting/acquisition of 4,245 Restricted Stock Units and the sale of 1,997 common shares on 09/11/2025 at $25.365 per share.

How many Restricted Stock Units vested and what rights do they include?

The filing shows 4,245 RSUs vested; each RSU represents the right to one share and RSUs are entitled to dividend-equivalent rights on dividend record dates.

What is the vesting schedule for the RSUs referenced in the Form 4?

The RSUs are scheduled to vest one-quarter on 9/11/2024, one-quarter on 9/11/2025, and one-half on 9/11/2026 as stated in the filing.

What beneficial ownership amounts are reported after the transactions?

The non-derivative table shows post-transaction beneficial ownership figures of 7,668 and 5,671 shares for the reported lines; the derivative table shows 8,498 shares underlying RSUs.

When was the Form 4 signed and by whom?

The Form 4 is signed by Allison A. Westfall, Attorney-in-Fact for Tamara Morytko on 09/15/2025.